Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Did Hedge Funds Drop The Ball On DENTSPLY SIRONA Inc. (XRAY) ?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of December. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One of their picks is DENTSPLY SIRONA Inc. (NASDAQ:XRAY), so let’s take a closer look at the sentiment that surrounds it in the current quarter.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has experienced a decrease in enthusiasm from smart money recently. XRAY was in 27 hedge funds’ portfolios at the end of December. There were 28 hedge funds in our database with XRAY positions at the end of the previous quarter. Our calculations also showed that XRAY isn’t among the 30 most popular stocks among hedge funds.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 32 percentage points since May 2014 through March 12, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.5% through March 12, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

D. E. Shaw

Let’s review the new hedge fund action regarding DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

How have hedgies been trading DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

At the end of the fourth quarter, a total of 27 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -4% from the previous quarter. On the other hand, there were a total of 33 hedge funds with a bullish position in XRAY a year ago. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).


Among these funds, Generation Investment Management held the most valuable stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY), which was worth $807.3 million at the end of the third quarter. On the second spot was Select Equity Group which amassed $182.9 million worth of shares. Moreover, Citadel Investment Group, Millennium Management, and D E Shaw were also bullish on DENTSPLY SIRONA Inc. (NASDAQ:XRAY), allocating a large percentage of their portfolios to this stock.

Seeing as DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has witnessed a decline in interest from the aggregate hedge fund industry, logic holds that there was a specific group of money managers who were dropping their full holdings by the end of the third quarter. Intriguingly, Jeffrey Ubben’s ValueAct Capital said goodbye to the biggest investment of the 700 funds tracked by Insider Monkey, comprising an estimated $83 million in stock. Samuel Isaly’s fund, OrbiMed Advisors, also said goodbye to its stock, about $71.3 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest fell by 1 funds by the end of the third quarter.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as DENTSPLY SIRONA Inc. (NASDAQ:XRAY) but similarly valued. These stocks are Tata Motors Limited (NYSE:TTM), Trimble Inc. (NASDAQ:TRMB), Targa Resources Corp (NYSE:TRGP), and Camden Property Trust (NYSE:CPT). This group of stocks’ market valuations are closest to XRAY’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
TTM 9 108095 0
TRMB 17 493848 0
TRGP 35 485408 14
CPT 19 301165 5
Average 20 347129 4.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 20 hedge funds with bullish positions and the average amount invested in these stocks was $347 million. That figure was $1421 million in XRAY’s case. Targa Resources Corp (NYSE:TRGP) is the most popular stock in this table. On the other hand Tata Motors Limited (NYSE:TTM) is the least popular one with only 9 bullish hedge fund positions. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard TRGP might be a better candidate to consider a long position. Our calculations showed that top 15 most popular stocks among hedge funds returned 21.3% through April 8th and outperformed the S&P 500 ETF (SPY) by more than 5 percentage points. Hedge funds were also right about betting on XRAY as the stock returned 35.5% and outperformed the market as well. You can see the entire list of these shrewd hedge funds here.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.